Conclusions Prescription opioid–dependent patients are most likely to reduce opioid use during buprenorphine-naloxone treatment; if tapered off buprenorphine-naloxone, even after 12 weeks of treatment, the likelihood of an unsuccessful outcome is high, even in patients receiving counseling in addition to SMM.
Trial Registration clinicaltrials.gov Identifier: NCT00316277 (Source: Archives of General Psychiatry)
Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial [Original Article]
Previous post: Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care
Next post: Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults.
